Drugs / rRp450
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01071941 | Oct 2010 → Jun 2024 | liver cancer | Kenneth K. Tanabe, MD | Terminated | No outcome recorded Stop: Business |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | rRp450 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01071941 ↗ |
| Modality | Gene therapy (AAV / viral vector) | “rRp450 is a type of gene therapy” NCT01071941 ↗ |
| Route | Other | “administration of rRp450 into the hepatic artery” NCT01071941 ↗ |